Valuation: Accuray Incorporated

Market Cap 30.89M 27.04M 24.96M 23.29M 43.87M 2.92B 44.66M 299M 116M 1.44B 116M 113M 5.02B P/E 2026 *
-0.68x
P/E 2027 * -0.96x
Enterprise Value 30.89M 27.04M 24.96M 23.29M 43.87M 2.92B 44.66M 299M 116M 1.44B 116M 113M 5.02B EV / Sales 2026 *
0.08x
EV / Sales 2027 * 0.07x
Free-Float
95.65%
Yield 2026 *
-
Yield 2027 * -
1 day+0.50%
1 week-20.94%
Current month-31.26%
1 month-33.14%
3 months-23.54%
6 months-67.63%
Current year-68.46%
1 week 0.25
Extreme 0.2475
0.35
1 month 0.25
Extreme 0.2475
0.41
Current year 0.25
Extreme 0.2475
0.93
1 year 0.25
Extreme 0.2475
2.1
3 years 0.25
Extreme 0.2475
4.3
5 years 0.25
Extreme 0.2475
5.93
10 years 0.25
Extreme 0.2475
6.39
Manager TitleAgeSince
Chief Executive Officer 67 2025-10-19
Director of Finance/CFO 46 2022-05-08
Chief Tech/Sci/R&D Officer - 2023-08-31
Director TitleAgeSince
Director/Board Member 66 2018-01-06
Chairman 68 2020-12-31
Director/Board Member 65 2019-09-05
Date Insider Type Main position Quantity % Market Cap.
05-28Free

Executive/Senior Manager

650,000 0.5472%
05-18
TCW Asset Management Co. LLC
OthersCompany 3,474,107 2.9248%
04-16
TCW Asset Management Co. LLC
OtherCompany 15,467,952 13.0221%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-20.94%-81.01%-93.28% 30.89M
-0.66%+7.01%+23.87%-3.74% 188B
-1.24%-0.72%-26.34%+17.06% 144B
-0.89%+6.61%-3.41%-20.50% 136B
-1.21%-6.72%-60.40%-21.36% 64.63B
-1.17%+3.70%+15.29%-4.41% 52.5B
+0.41%-0.93%-27.33%-34.05% 43.4B
-0.28%+4.29%+11.94%+9.86% 37.52B
+1.32%+4.19%+6.63%+39.63% 36.22B
-1.88%+0.17%-13.82%-21.43% 29.59B
Average -0.59%+2.33%-15.46%-13.22% 73.23B
Weighted average by Cap. -0.81%+5.68%-5.15%-4.05%

Financials

2026 *2027 *
Net sales 407M 356M 329M 307M 578M 38.47B 588M 3.94B 1.53B 18.98B 1.53B 1.49B 66.13B 413M 361M 333M 311M 586M 39.01B 596M 4B 1.55B 19.25B 1.55B 1.52B 67.06B
Net income -46.6M -40.79M -37.65M -35.12M -66.18M -4.41B -67.36M -452M -175M -2.17B -175M -171M -7.57B -34.05M -29.8M -27.51M -25.66M -48.35M -3.22B -49.22M -330M -128M -1.59B -128M -125M -5.53B
Net Debt - -
Logo Accuray Incorporated
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Employees
990
Date Price Change Volume
26-06-30 US$0.2601 +0.15% 766,203
26-06-29 US$0.2597 -1.85% 4,441,042
26-06-26 US$0.2646 -16.58% 11,976,869
26-06-25 US$0.3172 -3.91% 530,476
26-06-24 US$0.3301 +0.33% 883,189
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.2597USD
Average target price
0.3500USD
Spread / Average Target
+34.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARAY Stock